首页> 外文期刊>Diabetes, obesity & metabolism >Effects of chronic treatment with acarbose on glucose and lipid metabolism in obese diabetic Wistar rats.
【24h】

Effects of chronic treatment with acarbose on glucose and lipid metabolism in obese diabetic Wistar rats.

机译:慢性处理对胃癌糖尿病大鼠葡萄糖和脂质代谢的影响。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

AIMS: The effect of chronic treatment with acarbose on fasting plasma glucose, insulin, triglyceride, cholesterol and free fatty acid (FFA) concentrations, as well as on the glucose and insulin excursions during oral glucose tolerance test (OGTT), in obese diabetic Wistar (WDF) rats was investigated. METHODS: Forty-five mature male WDF rats were randomly distributed to one of the three treatment groups (no acarbose, 20 mg and 40 mg of acarbose/100 g of chow, respectively). After 3.5, 7.5 and 11.5 months, animals were tested for glucose tolerance by means of an OGTT, and their respective metabolic profiles were determined. Control determinations were done in obese and age-matched lean animals before the start of the trial. RESULTS: The WDF rats exhibit higher body weight and fasting blood glucose, insulin, triglyceride and cholesterol concentrations compared to lean animals. Moreover, they show marked glucose intolerance as indicated by the glucose and insulin excursions during OGTT. Interestingly, in both treated and untreated animals, a reversion of the hyperglycaemic state as well as an improvement of the glucose tolerance is observed. However, whereas in the group receiving no acarbose this is accounted for by dramatic increases in fasting plasma insulin concentrations and insulin secretion during OGTT (as indicated by the DeltaInsulin area), in rats treated with acarbose the reversion of the diabetic state takes place without increments in hormone concentration. In addition, rats treated with acarbose for 3.5 and 7.5 months show lower plasma triglyceride and FFA concentrations, and the same was observed for cholesterol at the highest dosage of the drug. CONCLUSIONS: Chronic treatment with acarbose of WDF rats improves the glycaemic and lipidic control as well as the glucose tolerance, with a lower demand of pancreatic insulin than in untreated rats. This data suggests that the long-term modulation of glucose and insulin excursions after meals improves the insulin sensitivity in this rat strain.
机译:旨在:慢性处理与氨基糖对肥胖糖尿病患者(OGTT)的血管糖,胰岛素,胰蛋白酶,胆固醇和游离脂肪酸(FFA)浓度的影响(WDF)大鼠进行了调查。方法:将四十五种成熟的雄性WDF大鼠随机分布到三种治疗组中的一种(分别没有氨基糖,20mg和40mg氨基糖/ 100g。 3.5,7.5和11.5个月后,通过OGTT测试动物的葡萄糖耐量,并确定它们各自的代谢谱。在试验开始之前,在肥胖和年龄匹配的精益动物中进行控制测定。结果:与贫动物相比,WDF大鼠具有更高的体重和空腹血糖,胰岛素,甘油三酯和胆固醇浓度。此外,它们显示出在OGTT期间葡萄糖和胰岛素偏移所示的标记葡萄糖不耐受。有趣的是,在治疗和未处理的动物中,观察到血液血糖状态的逆转以及改善葡萄糖耐量。然而,而在接受的基团中,无胶粘剂,由于禁食血浆胰岛素浓度和胰岛素分泌在OGTT期间(如列列蛋白区域所示)的急性增加,而在用氨基糖处理的大鼠中,糖尿病患者的逆转情况无增量在激素浓度。此外,用缺氧治疗的大鼠3.5和7.5个月,显示出低血浆甘油三酯和FFA浓度,并且在药物最高剂量的胆固醇中观察到相同的血浆甘油三酯。结论:慢性治疗WDF大鼠的氨基糖改善血糖和脂质对照以及葡萄糖耐量,胰岛素的需求低于未处理的大鼠。该数据表明,膳食后葡萄糖和胰岛素偏移的长期调节提高了该大鼠菌株中的胰岛素敏感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号